- Home
- »
- Medical Devices
- »
-
Vaporized Hydrogen Peroxide Sterilizers Market Report, 2033GVR Report cover
Vaporized Hydrogen Peroxide Sterilizers Market (2026 - 2033)
Size, Share, & Trends Analysis Report By Product Type (Capacity / Model-Based) (Compact / Low-capacity sterilizers, Mid-capacity sterilizers, High-capacity sterilizers), By Modality, By Sterilization, By End User, By Region, And Segment Forecasts
Market Size, 2025
$662.0MMarket Estimate, 2026
$725.4MMarket Forecast, 2033
$1,543.3MCAGR, 2026–2033
11.4%Vaporized Hydrogen Peroxide Sterilizers Market Summary
The global vaporized hydrogen peroxide sterilizers market size was valued at USD 662.0 million in 2025 and is projected to grow from USD 725.4 million in 2026 to USD 1,543.3 million by 2033, at a CAGR of 11.4% from 2026 to 2033. The market in North America dominated with a revenue share of 42.5% in 2025. The Vaporized Hydrogen Peroxide (VHP) sterilizers market is expanding rapidly due to the increasing incidence of healthcare-associated infections (HAIs), which has created a strong need for reliable, effective sterilization methods across hospitals and clinical settings.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By product type: High-capacity segment held the largest market share of 41.8% in 2025.
- By modality: Floor-standing (large-capacity) segment held the largest market share in 2025.
- By sterilization capability: Mixed-load capability segment held the largest market share in 2025.
Regional Highlights
- Largest regional market: North America (42.5% revenue share, 2025)
- By country: The U.S. held the largest market share in 2025
Market Size & Forecast
- Market size in 2025: USD 662.0 Million
- Estimated market size in 2026: USD 725.4 Million
- Projected market size by 2033: USD 1,543.3 Million
- CAGR (2026-2033): 11.4%
Prism AI by Grand View Research Free to tryAsk a question about the vaporized hydrogen peroxide sterilizers marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →
As healthcare systems place greater emphasis on infection control and patient safety, the adoption of advanced sterilization technologies such as VHP systems has accelerated significantly. Another important factor supporting market growth is the rising demand for low-temperature sterilization. Many modern medical devices are sensitive to heat and moisture, making VHP sterilizers a suitable and efficient alternative to conventional methods. In addition, the growth of healthcare infrastructure, the increasing number of surgical procedures, and the expanding pharmaceutical and biotechnology sectors are further driving demand.
To learn more about this report,Download Free Sample Report
The rising incidence of healthcare-associated infections (HAIs) is significantly supporting the growth of the Vaporized Hydrogen Peroxide (VHP) sterilizers market, as healthcare facilities prioritize effective infection control measures. HAIs pose serious risks to patient safety and lead to longer hospital stays and higher treatment costs, creating a strong need for reliable sterilization solutions. According to the WHO, healthcare-associated infections remain a major and persistent challenge worldwide in 2025. They affect about 7% of patients in high-income countries and up to 15% in low- and middle-income nations. These infections not only threaten patient safety but also lead to higher morbidity and mortality rates, along with a decline in overall quality of life. VHP sterilizers are widely adopted due to their ability to eliminate a broad range of microorganisms, including bacteria, viruses, and spores, without leaving harmful residues. As a result, hospitals and healthcare providers are investing in VHP systems to maintain sterile environments, reduce infection rates, and comply with stringent hygiene standards, thereby driving market expansion.
U.S. Hospital Infection Statistics - CLABSI, CAUTI, and VAE by State and Location, 2024
2024
Central line-associated bloodstream infections (CLABSI)
Catheter-associated urinary tract infections (CAUTI)
Ventilator-associated events (VAE)
Inpatient Locations
Inpatient Locations
Inpatient Locations
State
Total
ICU
Wards
NICU
Total
ICU
Wards
Total
ICU
Wards
Alabama
545
146
375
24
531
146
385
86
69
17
Alaska
59
10
43
6
56
10
46
9
8
1
Arizona
484
100
362
22
468
100
368
43
36
7
Arkansas
347
65
245
37
325
65
260
37
34
3
California
2,895
566
2,069
260
2,667
566
2,101
405
288
117
Colorado
433
80
318
35
408
80
328
73
59
14
Connecticut
Upgrade report license to gain access to the complete analysis.
D.C.
Delaware
Florida
Georgia
Guam
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virgin Islands
Virginia
Washington
West Virginia
Wisconsin
Wyoming
All US
29,837
5,726
22,182
1,929
28,427
5,721
22,706
4,512
3,066
1,446
Source: CDC, 2026
Strict regulatory standards are driving growth in the Vaporized Hydrogen Peroxide (VHP) sterilizers market by setting high requirements for sterilization and infection control. Organizations such as the U.S. Food and Drug Administration and the World Health Organization have set clear guidelines for maintaining sterile conditions and safely reprocessing medical devices.
-
For instance, in 2024, the U.S. Food and Drug Administration updated its final guidance titled Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile. The agency recognized vaporized hydrogen peroxide (VH2O2) as an Established Category A sterilization process following its acknowledgment of the International Organization for Standardization’s ISO Standard 22441:2022, which outlines requirements for the development, validation, and routine control of low-temperature VH2O2 sterilization processes for medical devices.
These requirements encourage healthcare providers and manufacturers to use reliable, approved sterilization methods. As a result, VHP systems are adopted for their effectiveness and suitability for sensitive equipment, thereby supporting market expansion.
The expansion of healthcare infrastructure and the growing number of surgical procedures are significantly supporting the growth of the VHP sterilizers market. As new hospitals, clinics, and surgical centers are established, the need for reliable sterilization systems to maintain sterile environments has increased. At the same time, the rising volume of surgeries has led to greater use of medical instruments that require frequent, effective sterilization.
According to the American College of Surgeons in 2025, a 20-year meta-analysis aggregating 360 studies covering 211,078 robotic and 1,358,201 laparoscopic abdominal procedures across 30 countries highlights a significant rise in global surgical volumes. The growing number of procedures increases the need for effective sterilization of complex surgical instruments, thereby supporting the adoption of Vaporized Hydrogen Peroxide (VHP) sterilizers in healthcare settings.
Market Concentration & Characteristics
The Vaporized Hydrogen Peroxide sterilizers market is growing as demand for advanced sterilization solutions increases across healthcare, pharmaceutical, and laboratory settings. The presence of established players along with emerging companies is driving innovation and product development. Companies are focusing on improving efficiency, automation, and compliance with strict regulatory standards. Key characteristics include strong investment in research and development, adoption of portable and automated systems, and integration of advanced monitoring technologies. In addition, strategic partnerships, product launches, and geographic expansion are supporting competition and contributing to overall market growth.
To learn more about this report,Download Free Sample Report
-
The degree of innovation has a strong impact on the growth of the Vaporized Hydrogen Peroxide (VHP) sterilizers market by improving efficiency, reliability, and usability of sterilization systems. Advancements such as faster sterilization cycles, automated operations, and real-time monitoring technologies have enhanced performance and reduced processing time. Innovations in compact, portable designs have expanded their use across various healthcare and laboratory settings. In addition, the development of more precise and controlled sterilization processes has improved safety and compatibility with sensitive medical devices, encouraging wider adoption and supporting overall market expansion.
-
In 2026, Picarro Inc. announced the introduction of the PI2124 Analyzer, a solution designed for monitoring vaporized hydrogen peroxide (VHP) in pharmaceutical and other regulated manufacturing settings. The system enables continuous detection of VHP at concentrations as low as 3 ppb. It incorporates software upgrades that enhance data accuracy, support audit processes, and improve overall operational efficiency and compliance.
-
-
Regulations have a significant impact on the Vaporized Hydrogen Peroxide (VHP) sterilizers market by shaping product development, approval processes, and adoption across industries. Regulatory bodies such as the U.S. Food and Drug Administration and the International Organization for Standardization establish strict guidelines for sterilization validation, safety, and performance. These requirements encourage manufacturers to develop highly reliable, compliant systems, thereby improving overall product quality. At the same time, compliance with evolving standards can increase development costs and extend approval timelines. However, these regulations also build trust among healthcare providers and pharmaceutical companies, leading to greater adoption of validated technologies such as VHP sterilizers. In addition, regulatory recognition of hydrogen peroxide-based sterilization methods has further supported their acceptance, contributing to steady market growth.
-
In 2025, according to SGS, they received the updates from the European Union’s medical device regulatory framework, which expanded the scope of sterilization certification to include vaporized hydrogen peroxide (VHP) processes aligned with ISO 22441. This allowed notified bodies to formally assess VHP-based sterilization methods, strengthening compliance pathways for manufacturers and encouraging wider adoption of VHP technologies across Europe.
-
-
Mergers and acquisitions (M&A) are shaping the Vaporized Hydrogen Peroxide (VHP) sterilizers market by driving expansion and technological advancement. Companies are pursuing strategic deals to broaden their product offerings, access new capabilities, and strengthen their presence in different regions. These activities also enable the combination of complementary technologies, improving overall solutions. In addition, consolidation helps organizations improve efficiency and scale their operations. As a result, increasing M&A activity is contributing to innovation, stronger competition, and continued market development.
-
In 2025, Healthcare Holding Schweiz AG completed the acquisition of Ino Medical Solutions GmbH, based in Rapperswil-Jona. Ino Medical is a specialized provider of sterile containers and medical instruments, serving sterilization centers, university and cantonal hospitals, and private hospital groups across Switzerland.
-
-
Regional expansion in the Vaporized Hydrogen Peroxide (VHP) sterilizers market is being driven by the development of healthcare infrastructure, increasing awareness of infection control, and rising demand for advanced sterilization solutions across emerging economies. Companies are actively expanding their distribution channels, establishing regional facilities, and forming partnerships with local healthcare and pharmaceutical organizations to strengthen their presence. Regions such as Asia-Pacific, Latin America, the Middle East, and Africa are seeing increased investment in hospitals, cleanrooms, and laboratory facilities, which is supporting the adoption of VHP sterilization technologies.
-
In 2025, BGS Beta-Gamma-Service expanded its operations by opening a new sterilization facility in Pittsburgh, United States. This development was intended to increase capacity for advanced sterilization solutions, particularly for heat-sensitive medical devices.
-
“A lack of sterilization capacity has put pressure on US medical equipment manufacturers and could potentially cause supply bottlenecks. With our new facility in Pittsburgh, we are helping to eliminate them.” - Dr. Andreas Ostrowicki, Managing Director of BGS Beta-Gamma-Service.
Product Type (Capacity / Model-Based) Insights
High-capacity vaporized hydrogen peroxide sterilizers dominated the market in 2025 primarily due to their widespread adoption in large hospitals, pharmaceutical manufacturing facilities, and centralized sterilization units. These systems can process large volumes of medical instruments and equipment in a single cycle, making them highly efficient for facilities with heavy patient inflow and surgical workloads. The increasing number of surgical procedures and the growing need to control hospital-acquired infections significantly boosted demand for large-scale sterilization solutions. In addition, stringent regulatory requirements for infection control and sterilization in healthcare and biopharma industries further support the dominance of high-capacity systems, as they offer faster turnaround times and consistent sterilization performance across bulk loads.
Compact or low-capacity VHP sterilizers are expected to witness the fastest CAGR due to their increasing adoption in smaller healthcare facilities, ambulatory surgical centers, and laboratories. These systems are cost-effective, space-efficient, and easier to install, making them ideal for decentralized healthcare settings and emerging markets. The growing demand for point-of-care sterilization and flexible, portable solutions is accelerating their adoption. Moreover, technological advancements have enabled compact systems to deliver sterilization performance comparable to that of larger units, further driving their popularity. The expansion of outpatient care facilities and rising awareness of infection prevention in smaller settings are key drivers of this segment's rapid growth.
Modality Insights
The floor-standing (large-capacity) segment dominated the Vaporized Hydrogen Peroxide (VHP) sterilizers market in 2025 due to its widespread use in hospitals, pharmaceutical production facilities, and large-scale research facilities that require high-throughput sterilization. These systems are designed to handle bulk loads of medical devices, instruments, and equipment in a single cycle, making them highly efficient for environments with continuous and high sterilization demand. The rising number of surgical procedures, along with increasing emphasis on infection prevention and strict sterilization standards, further supported their adoption. In addition, their ability to deliver consistent, validated sterilization for large volumes and complex equipment made them the preferred choice for centralized sterilization departments and industrial applications.
The benchtop or tabletop (small-capacity) segment is expected to grow at the fastest CAGR, driven by increasing demand from smaller healthcare settings, including clinics, ambulatory surgical centers, and laboratories. These compact systems are space-saving, cost-effective, and easy to operate, making them suitable for facilities with limited infrastructure and lower sterilization volumes. The growing trend toward decentralized healthcare and point-of-care services has accelerated their adoption. Furthermore, ongoing technological advancements have enhanced the efficiency and reliability of smaller units, enabling them to meet stringent sterilization requirements while offering flexibility and convenience, which is contributing to their rapid market growth.
Sterilization Capability Insights
The mixed-load capability segment dominated the Vaporized Hydrogen Peroxide (VHP) sterilizers market in 2025 due to its ability to process a wide range of medical instruments and materials, including metals, plastics, and heat-sensitive devices, in a single sterilization cycle. This versatility significantly improved workflow efficiency in hospitals, pharmaceutical facilities, and laboratories by reducing the need for multiple sterilization processes. The increasing demand for operational efficiency, coupled with rising surgical volumes and strict infection control protocols, drove the adoption of systems capable of handling mixed loads. In addition, VHP sterilization's compatibility with a broad range of devices without causing material damage made it a preferred choice for healthcare providers seeking reliable, time-saving sterilization solutions.
The flexible endoscopes segment is expected to grow at the fastest CAGR, driven by the increasing use of minimally invasive diagnostic and therapeutic procedures. Flexible endoscopes are highly sensitive to heat and moisture, making VHP sterilization an ideal method due to its low-temperature and material-friendly properties. The rising prevalence of gastrointestinal, respiratory, and urological disorders has driven greater demand for endoscopic procedures, thereby increasing the need for effective sterilization of these devices. Furthermore, growing awareness regarding infection risks associated with improperly sterilized endoscopes and stricter reprocessing guidelines are accelerating the adoption of VHP sterilizers for this segment.
End User Insights
Hospitals, particularly Central Sterile Supply Departments (CSSD) and Sterile Processing Departments (SPD), dominated the Vaporized Hydrogen Peroxide (VHP) sterilizers market in 2025 due to their critical role in managing large-scale sterilization needs. These departments handle high volumes of surgical instruments and medical devices daily, requiring reliable, high-capacity sterilization systems. The increasing number of surgical procedures, along with the growing burden of hospital-acquired infections, reinforced the demand for advanced sterilization technologies such as VHP systems. In addition, strict regulatory standards and infection control protocols in hospital settings further supported the adoption of VHP sterilizers, as they provide effective low-temperature sterilization for heat-sensitive instruments while ensuring operational efficiency and patient safety.
To learn more about this report,Download Free Sample Report
Ambulatory Surgical Centers (ASCs) are expected to witness the fastest CAGR in the Vaporized Hydrogen Peroxide (VHP) sterilizers market, driven by the global shift toward outpatient and same-day surgical procedures. ASCs require compact, efficient, and cost-effective sterilization solutions to manage instrument turnaround within limited space and infrastructure. The growing preference for minimally invasive procedures, shorter hospital stays, and reduced healthcare costs has accelerated the expansion of ASCs, thereby increasing demand for VHP sterilizers. Furthermore, rising awareness of infection prevention and the need for compliance with sterilization standards in outpatient settings are encouraging ASCs to adopt advanced, low-temperature sterilization technologies, supporting rapid segment growth.
Regional Insights
North America dominated the Vaporized Hydrogen Peroxide sterilizers market with the largest revenue share 42.5% in 2025. The North America vaporized hydrogen peroxide (VHP) sterilization market is growing due to advanced healthcare infrastructure, a strong emphasis on infection control, and the rising incidence of healthcare-associated infections (HAIs). These infections include surgical site infections, catheter-associated urinary tract infections, bloodstream infections, and ventilator-associated pneumonia, all of which drive the need for effective sterilization solutions.
To learn more about this report,Download Free Sample Report
In 2025, according to the Canadian Journal of Infection Control. During the study period, 2,493 patients were included. Among these, 50 patients had 56 HAIs (4.4 cases per 1,000 patient-days) identified during their PICU stay. The overall incidence rate for all HAI types across the study periods was 4.4 per 1,000 patient-days, with the highest rate reported in the pandemic period (5.1 per 1,000 patient-days). However, the difference in incidence rates between the study periods was not significant.
The high volume of surgical procedures and use of complex medical devices further increases demand. In addition, strict regulatory standards and the presence of well-established pharmaceutical and biotechnology industries are supporting the adoption of VHP sterilization technologies across the region.
The U.S. Vaporized Hydrogen Peroxide (VHP) sterilizers market is experiencing steady expansion, driven by a well-established healthcare system and rigorous standards for infection prevention and control. Growing concerns about healthcare-associated infections have increased the need for highly reliable sterilization methods, especially for delicate, heat-sensitive medical instruments that cannot withstand traditional high-temperature processes.
In 2026, according to the CDC's 2024 National and State Healthcare-Associated Infections Progress Report, each day in the U.S., a significant proportion of patients, about one in 31 in hospitals and one in 43 in nursing homes, acquired at least one infection linked to their care. This highlighted ongoing gaps in infection prevention and the need to further strengthen patient safety practices across healthcare settings. Although notable advancements had been made in reducing these infections, continued efforts and improved strategies were still essential to effectively minimize healthcare-associated infections across diverse care environments. This has encouraged healthcare facilities to adopt VHP technology for its effectiveness and compatibility with various materials.
Europe Vaporized Hydrogen Peroxide Sterilizers Market Trends
The Europe VHP sterilizers market is growing, due to a strong emphasis on infection control and well-defined regulatory standards across the region. Strict policies governing medical device sterilization and contamination prevention have encouraged healthcare facilities to adopt advanced technologies, such as vaporized hydrogen peroxide systems. Growing awareness of healthcare-associated infections and the importance of patient safety has further increased demand for efficient sterilization solutions.
According to the NLM, in 2025, nearly 4.3 million patients admitted to hospitals across the European Union and the European Economic Area developed healthcare-associated infections, placing considerable strain on healthcare systems and affecting patient outcomes. In addition, Europe’s well-developed pharmaceutical and biotechnology industries rely heavily on sterile environments, driving the use of VHP systems in production and research settings.
Urinary incontinence in the UK is driving growth in the Vaporized Hydrogen Peroxide (VHP) sterilizers market by increasing demand for effective infection control and hygiene management in healthcare settings. The high prevalence of urinary incontinence, particularly among the elderly and patients in long-term care facilities, has led to greater use of urinary catheters and related medical devices, which require strict sterilization to prevent infections such as catheter-associated urinary tract infections (CAUTIs). This has heightened the need for advanced, low-temperature sterilization technologies, such as VHP systems, that ensure patient safety while preserving delicate equipment. In addition, the growing burden on hospitals and nursing homes to maintain high standards of cleanliness and reduce infection risks has further supported the adoption of VHP sterilizers across the UK healthcare sector.
Prevalence and Impact of Urinary Incontinence in the UK (2025)
Category
Key Statistic / Impact (UK)
Prevalence of bladder problems
1 in 5 people experience bladder problems (~14 million people)
Women affected
Around 1 in 3 women (34%) live with urinary incontinence
Men affected
Over 2 million men experience urinary incontinence
Hospital-acquired UTIs
Incontinence increases risk of hospital-acquired UTIs
Impact on hospital stay
Hospital-acquired UTIs extend length of stay by ~6 days
Care home residents
Over 50% of care home residents have urinary incontinence
Source: The Urology Foundation
The German Vaporized Hydrogen Peroxide (VHP) sterilizers market is growing due to its strong healthcare infrastructure, stringent infection-control regulations, and strong emphasis on patient safety. The country enforces strict hygiene and sterilization standards, encouraging healthcare facilities to adopt advanced technologies such as vaporized hydrogen peroxide systems. Increasing surgical procedures and the need for safe reprocessing of medical devices have further driven demand for reliable sterilization methods. In addition, Germany’s well-developed pharmaceutical and biotechnology industries require highly controlled sterile environments, supporting the use of VHP sterilizers.
In 2025, according to the National Library of Medicine, a study on the characteristics of pediatric SARS-CoV-2 healthcare-associated infection outbreaks in Germany (2020-2023) reported 36,371 healthcare-associated infection cases from hospital outbreaks, of which 241 were pediatric cases, indicating a comparatively smaller proportion among pediatric populations. This highlighted the ongoing risk of infection transmission in healthcare settings and showed the need for effective sterilization solutions such as VHP sterilizers.
Asia Pacific Vaporized Hydrogen Peroxide Sterilizers Market Trends
The Asia Pacific Vaporized Hydrogen Peroxide (VHP) sterilizers market is growing due to rapidly expanding healthcare infrastructure, increasing awareness of infection control, and rising healthcare investments across the region. The growing number of hospitals, surgical procedures, and patient admissions in countries such as China, India, and Japan has significantly increased the demand for advanced sterilization technologies. In addition, the rising number of healthcare-associated infections (HAIs) has heightened the need for effective sterilization solutions, prompting healthcare providers to adopt low-temperature technologies such as VHP systems. The expansion of pharmaceutical and biotechnology industries, along with increasing demand for cleanroom environments, has further supported market growth.
The India Vaporized Hydrogen Peroxide (VHP) sterilizers market is growing due to increasing government investments in healthcare infrastructure, rising focus on infection control, and expansion of hospitals and medical facilities across the country. Government initiatives aimed at strengthening healthcare delivery, particularly in rural and underserved areas, have improved access to quality care and modern equipment.
-
In 2025, according to the Indian Brand Equity Foundation, the government allocated USD 11.50 billion to the healthcare sector in the Union Budget 2025-26 for the development, maintenance, and enhancement of the country’s healthcare system. This reflected a 9.78% increase from the previous allocation of USD 10.47 billion in FY25.
The rising burden of healthcare-associated infections and the growing number of surgical procedures have increased the need for effective sterilization solutions. In addition, the adoption of advanced medical technologies and the expansion of pharmaceutical and biotechnology sectors are driving demand for reliable sterilization systems.
The JapanVaporized Hydrogen Peroxide (VHP) sterilizers market is growing due to its advanced healthcare system, strong emphasis on infection control, and increasing demand for high-quality medical services. The country’s rapidly aging population has led to a higher prevalence of chronic conditions and increased hospital admissions, which in turn has raised the need for effective sterilization practices to ensure patient safety. In 2025, according to the World Economic Forum, Japan's Ministry of Internal Affairs and Communications reported that, as of 2024, the country had a record 36.25 million people aged 65 and over, accounting for 29.3% of the total population. This share is projected to rise to 34.8% in 2040 and 36.3% in 2045. Japan's proportion of elderly residents is already far higher than second-ranked Martinique (25.3%), making it the world's most aged society.
In addition, Japan maintains strict hygiene and regulatory standards for medical device reprocessing, encouraging the adoption of advanced technologies such as vaporized hydrogen peroxide systems. The expansion of pharmaceutical manufacturing, biotechnology research, and cleanroom applications has further driven demand for reliable sterilization solutions.
Latin America Vaporized Hydrogen Peroxide Sterilizers Market Trends
The Latin America Vaporized Hydrogen Peroxide (VHP) sterilizers market is growing due to increased emphasis on infection prevention, improved healthcare infrastructure, and rising awareness of hospital hygiene standards across the region. Governments in countries such as Brazil and Mexico are strengthening infection control programs and implementing stricter sterilization guidelines, encouraging healthcare facilities to adopt advanced technologies such as VHP systems. In 2025, according to the International Trade Administration, Brazil’s Unified Healthcare System (SUS) was the sole provider of health services for approximately 72% of the population (164 million people). At the same time, 51 million Brazilians also had access to the private healthcare system, according to the Brazilian Institute of Geography and Statistics (IBGE).
In addition, the growing burden of healthcare-associated infections has heightened demand for effective, reliable sterilization solutions. The expansion of hospitals, the rising number of surgical procedures, and growing investments in healthcare services are further supporting market growth.
MEA Vaporized Hydrogen Peroxide Sterilizers Trends
The Middle East & Africa (MEA) Vaporized Hydrogen Peroxide (VHP) sterilizers market is expanding due to growing healthcare investments, increased focus on infection control, and ongoing improvements in healthcare services across the region. Countries such as the UAE, Saudi Arabia, and South Africa are actively developing hospital infrastructure and upgrading medical facilities, driving the need for advanced sterilization methods.
According to the Saudi Medical Journal, in October 2025, the QHC’s PHM implementation will, over the coming decades, drastically shift healthcare practices toward a more sustainable system aligned with Vision 2030. To guarantee the successful operation of PHM in the QHC and other health clusters, more advocacy for institutional support, technical assistance, adequate funding, and sponsorship is required. A rising incidence of healthcare-associated infections, along with an increase in surgical procedures, has heightened demand for reliable sterilization solutions.
Key Vaporized Hydrogen Peroxide Sterilizers Company Insights
The Vaporized Hydrogen Peroxide (VHP) sterilizers market is highly competitive, with key players holding significant market share. Major companies are pursuing various organic and inorganic strategies, such as new product development, collaborations, acquisitions, mergers, and regional expansion, to meet their customers' unmet needs.
Key Vaporized Hydrogen Peroxide Sterilizers Companies:
The following key companies have been profiled for this study on the vaporized hydrogen peroxide pterilizers market.
- DE LAMA S.P.A.
- Getinge
- Scitek Global
- Canon Singapore
- Ecolab
- Fedegari Group
- Zhejiang Tailin Bioengineering
- Shinva Medical Instrument
- STERIS
- Steelco S.p.A.
Recent Developments
-
In March 2026, Picarro Inc., a global provider of high-precision gas analysis solutions, announced the introduction of the PI2124 Analyzer for monitoring vaporized hydrogen peroxide (VHP) in pharmaceutical and other regulated manufacturing environments. The system was designed to continuously detect VHP concentrations at very low levels, down to 3 ppb, while incorporating advanced software to improve data accuracy, support regulatory compliance, and enhance operational efficiency in routine processes.
-
In September 2025, the Society for Sterility Assurance Professionals (SfSAP) launched a new Working Group dedicated to Vaporized Hydrogen Peroxide (VHP) sterilization. SfSAP, a non-profit professional association established collaboratively by the International Irradiation Association, AAMI, and PDA, aims to support the sterility assurance community by developing standardized competency and training frameworks for professionals and organizations involved in sterilizing medical and pharmaceutical products.
-
In June 2025, Solventum announced the launch of its Attest Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack, a preassembled, see-through test pack for low-temperature medical instrument sterilization. This innovative solution integrates both a biological indicator (BI) and a chemical indicator (CI) into a single, ready-to-use design, enabling monitoring of every load across multiple sterilizer brands, models, and cycle types.
Vaporized Hydrogen Peroxide Sterilizers Market Report Scope
Report Attribute
Details
Market size in 2025
USD 662.0 million
Estimated Market size in 2026
USD 725.4 million
Projected Market size by 2033
USD 1,543.3 million
Growth rate
CAGR of 11.4% from 2026 to 2033
Actual data
2021 - 2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million/billion and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product type (capacity / model-based), modality, sterilization capability, end user, and region
Regional scope
North America; Europe; Asia Pacific; Latin America; and MEA
Country scope
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Getinge, Scitek Global, Canon Singapore, Ecolab, Fedegari Group, Zhejiang Tailin Bioengineering, Shinva Medical Instrument, STERIS, Steelco S.p.A.
and others
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Vaporized Hydrogen Peroxide Sterilizers Market Report Segmentation
This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the vaporized hydrogen peroxide (VHP) sterilizers market report on the basis of product type (capacity / model-based), modality, sterilization capability, end user, and region:
-
Product Type (Capacity / Model-Based) Outlook (Revenue, USD Million, 2021 - 2033)
-
Compact / Low-capacity sterilizers
-
Mid-capacity sterilizers
-
High-capacity sterilizers
-
-
Modality Outlook (Revenue, USD Million, 2021 - 2033)
-
Floor-standing (Large Capacity)
-
Benchtop/Tabletop (Small Capacity)
-
-
Sterilization Capability Outlook (Revenue, USD Million, 2021 - 2033)
-
Non-lumen devices
-
Lumen devices
-
Flexible endoscopes
-
Mixed load capability
-
-
End User Outlook (Revenue, USD Million, 2021 - 2033)
-
Hospitals (CSSD/SPD)
-
Ambulatory Surgical Centers (ASCs)
-
Pharmaceutical & Biotechnology companies
-
Medical device manufacturers
-
-
Region Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
The high-capacity segment led with a 41.8% revenue share in 2025, while compact or low-capacity VHP sterilizers is the fastest-growing segment.
Floor-standing (large-capacity) held the largest revenue share in 2025.
Mixed-load capability held the largest share in 2025, and flexible endoscopes is the fastest-growing market.
The global vaporized hydrogen peroxide sterilizers market size was estimated at USD 662.0 million in 2025 and is projected to grow from USD 725.4 million in 2026.
The global vaporized hydrogen peroxide sterilizers market is expected to grow at a compound annual growth rate of 11.4% from 2026 to 2033, reaching USD 1,543.3 million by 2033.
North America dominated with a 42.5% revenue share in 2025.
Some key players operating in the vaporized hydrogen peroxide (VHP) sterilizers market include DE LAMA S.P.A., Getinge, Scitek Global, Canon Singapore, Ecolab, Fedegari Group, Zhejiang Tailin Bioengineering, Shinva Medical Instrument, STERIS, and Steelco S.p.A.
The vaporized hydrogen peroxide sterilizers market is growing due to increasing concerns about hospital-acquired infections and the rising number of surgical procedures, which are driving demand for effective, reliable sterilization solutions.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.